In the wake of
SAS Institute v. Iancu, the PTAB has sometimes expanded
pending IPRs to include previously un-instituted grounds. But can
the PTAB rely on SAS to retroactively deny
institution? A recent decision says yes, in at least some
circumstances. And while the facts of this case are unusual, it
nevertheless demonstrates that petitioners should be cautious when
relying on SAS to try to induce the PTAB to reconsider
grounds that it didn't originally find persuasive.
In BioDelivery Sciences
International, Inc. v. Aquestive Therapeutics, Inc. f/k/a MonoSol
Rx LLC , the PTAB instituted trial on only a subset of
claims from one out of seven grounds, and later upheld the
challenged claims in its final written decision. SAS was
decided while BioDelivery's appeal was pending, so BioDelivery
asked the Federal Circuit to remand to the PTAB to reconsider the
non-instituted grounds. The Federal Circuit agreed, over the patent
owner's and USPTO's objections. On remand,